APOB and cancer: Ahmadreza Niavarani et al. found that strong expression of apolipoprotein B mRNA editing enzyme catalytic subunit 1 (APOBEC1) was associated with short survival time in pan-cancer, which was in line with our result (Niavarani et al., 2018).